Outside of Massachusetts, AstraZeneca said its expanding U.S. footprint includes a manufacturing facility for biologics in Maryland, cell therapy manufacturing capacity on the West and East Coasts ...
AstraZeneca made headlines for several reasons on Tuesday ... The investment will also support creation of a new next generation manufacturing facility, focused on biologics, in Maryland as well as ...
(RTTNews) - British drug maker AstraZeneca Plc (AZN.L ... a next generation manufacturing facility for biologics in Maryland; Cell therapy manufacturing capacity on the West and East Coasts ...
AstraZeneca’s expanding footprint in the US includes, among others: A state-of-the-art R&D centre in Kendall Square, Cambridge, Massachusetts; A next generation manufacturing facility for biologics in ...
many of the projects AstraZeneca outlined are, in fact, not exactly new. For instance, the company announced plans for its cell therapy facility in Rockville, Maryland back in February.
The new investments will expand manufacturing sites in Maryland, Texas and California. But AstraZeneca shares have fallen nearly 6% this year, underperforming a near 9% rise in the wider European ...
Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions ... a next-generation biologics manufacturing facility in Maryland, specialty manufacturing in Texas and cell ...